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During an 8-year study period, Arcobacter butzleri was
the fourth most common Campylobacter-like organism iso-
lated from 67,599 stool specimens. Our observations sug-
gest that A. butzleri displays microbiologic and clinical
features similar to those of Campylobacter jejuni; however,
A. butzleri is more frequently associated with a persistent,
watery diarrhea. 
C
ampylobacter is the most common cause of acute bac-
terial enteritis in the United States and many other
industrialized countries (1,2). When the diagnosis of infec-
tion is based exclusively on culturing on selective media,
>95% of Campylobacter infections are caused by
Campylobacter jejuni or  C. coli. However, with refine-
ments in isolation and identification methods, other related
species such as C. upsaliensis, C. jejuni subsp. doylei, C.
fetus  subsp fetus,  C. concisus,  Arcobacter butzleri,
Helicobacter fennelliae, and H. cinaedi, have emerged as
potential enteric human pathogens (3). Since most labora-
tories do not use appropriate culture conditions to detect all
Campylobacter spp. and related organisms or do not iden-
tify isolates to species level, data on the incidence and clin-
ical importance of these non–C. jejuni/coli organisms are
scarce.
During the past decade, improvements in isolation tech-
niques in veterinary medicine have led to the discovery of
Arcobacter  spp. as animal pathogens. Members of the
genus  Arcobacter are aerotolerant Campylobacter-like
organisms. They were first isolated from aborted bovine
fetuses by Ellis in 1977 (4). Arcobacter spp. differ from
Campylobacter spp. by their ability to grow at lower tem-
peratures and in air (5). Later, Arcobacter infections in
humans were also described. Two species, A. butzleri and,
more rarely, A. cryaerophilus, have been associated with
enteritis and occasionally bacteremia (6–9). Patients with
A. butzleri infections report diarrhea associated with
abdominal pain; nausea and vomiting or fever also occur
(10,11). Athird species, A. skirrowii, has recently been iso-
lated from a person with chronic diarrhea (12). Despite
these occasional reports, the contribution of Arcobacter
species to human diarrhea is still unknown. The aim of our
study was to compare the prevalence and the clinical fea-
tures of A. butzleri isolated from stools with those of
C. jejuni.
The Study
From January 1995 to December 2002, all stool sam-
ples submitted to two hospital laboratories serving the
Brugmann, Queen Fabiola, and Saint-Pierre University
Hospitals in Brussels, Belgium, were examined macro-
scopically for consistency, gross blood, and mucus and
microscopically for parasites, leukocytes, and erythro-
cytes. These samples were also cultured for common bac-
terial pathogens. Stool samples of patients <2 years of age
were also evaluated for rotavirus and enteric adenovirus
since viral diarrhea is mainly seen in young children.
A specific culture protocol for the recovery of
Campylobacter spp. and related organisms consisting of
one solid selective medium and a filtration method was
systematically applied. In the selective agar method, the
fecal suspension (approximately 1 g/mL of saline) was
plated onto Butzler’s medium comprising Mueller-Hinton
agar (Oxoid Ltd, Basingstoke, United Kingdom) contain-
ing 5% sheep blood and the antimicrobial supplement cef-
operazone 30 mg/L, rifampicin 10 mg/L, and amphotericin
B 2 mg/L (Institute Virion, Rüschlikon, Switzerland) (13).
The plates were incubated for 48 h at 42°C in a microaer-
obic atmosphere (5% O2, 6% H2, 10% CO2, and 79% N2).
The plates were examined daily for growth of
Campylobacter species. 
The membrane filtration method was performed
according to Lopez (14). Stool samples were diluted 1:5 in
Brucella broth. Cellulose acetate filters (50 mm in diame-
ter) with a pore size of 0.45 µm were placed on the surface
of Mueller-Hinton agar plates containing 5% sheep blood.
Eight drops of the fecal suspension were placed on the top
of the membrane and allowed to filter passively for 30 min
at 37°C in air. After filtration, the filters were removed,
and the plates were incubated at 37°C in a microaerobic
atmosphere for up to 10 days.
Two specific procedures for isolating Arcobacter were
used successively. Until April 1995, we used a membrane
filtration technique (15). Subsequently, we switched to
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which 0.5 g of stool samples was injected into an enrich-
ment broth (Brucella broth + antimicrobial supplement
consisting of piperacillin 75 mg/L, cefoperazone 25 mg/L,
amphotericin B 10 mg/L, trimethoprim 20 mg/L, and
cycloheximide 100 mg/L + 5% laked horse blood) and
incubated for 24 h at 25°C in a microaerobic atmosphere.
After incubation, 40 µL of enriched broth was plated onto
Arcobacter selective medium (16). The plates were then
incubated for 3 days at 25°C in a microaerobic atmosphere
and examined daily.
Gram-negative, motile, spiral, or curved rods were iden-
tified as Campylobacter by morphologic and biochemical
characteristics consistent with the genus Campylobacter, as
recommended by Vandamme et al. (5). A complementary
distinction between A. butzleri and A. cryaerophilus was
achieved by using sodium dodecyl sulfate–polyacrylamide
gel electrophoresis of whole-cell proteins and by a multi-
plex polymerase chain reaction assay (17). 
To assess the pattern of clinical disease, patients with A.
butzleri infection were matched against three randomly
selected control patients with C. jejuni infection. To
achieve this, all charts of patients with A. butzleri infection
and controls were reviewed retrospectively by combining
the records of the medical and microbiology departments.
Astructured, close-ended questionnaire was used to collect
the patient’s history, age, sex, status (outpatient or hospi-
talized for >48 h) and history of international travel. The
clinical history included diarrhea within the preceding 3
months, duration of symptoms, nature of the diarrhea
(watery or bloody and presence of cells), intensity of fever,
nausea or vomiting, abdominal pains, asymptomatic car-
riage (routine screening of enteric pathogens in stools of
HIV-infected persons, other immunocompromised states,
and patients from a foreign country referred for surgery),
and underlying disease. Diarrhea was defined as at least
three unformed or liquid stools per day for at least 3 days.
Because of the study’s retrospective nature, we could only
classify diarrhea as acute (duration <15 days) or chronic
(duration >15 days). Treatment history included antimicro-
bial history and use of intravenous fluid therapy, and, final-
ly, clinical status after 1 month of treatment (cure or
persistent diarrhea). 
All parameters were compared between index patients
and matched controls. Comparisons were made by Pearson
χ2 test for 1:3 control data. Odds ratios (OR) and 95% con-
fidence intervals (CI) were calculated. 
From January 1995 to December 2002, a total of 67,599
stool specimens from 40,995 patients were submitted for
bacteriologic stool culture. These cultures yielded
Campylobacter and related organisms in 1,906 patients,
Salmonella species in 1,720 patients, and Shigella species
in 244 patients. Other identified pathogens include
enteropathogenic Escherichia coli (137 patients), Yersinia
enterocolitica  (87 patients), Plesiomonas spp. (22
patients), and Aeromonas spp. (21 patients).
Among the 1,906 Campylobacter and related organ-
isms isolated during the study period, 77.2% were C. jeju-
ni, 11.4% were C. coli, and 4.5% were C. upsaliensis
(Table 1). Ninety-seven Arcobacter isolates were obtained
from 77 patients. Among them, A. butzleri was the most
frequently isolated species (84 isolates from 67 patients),
accounting for 3.5 % of the Campylobacter and related
organisms bacterial group. Thirteen A. cryaerophilus iso-
lates from 10 patients were obtained, but no A. skirrowii
isolates were found. Other species, such as C. concisus, C.
fetus, C. curvus, C. lari, and C. hyointestinalis, were also
found in small numbers (Table 1).
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with A. butzleri infection. Ages of patients with A. butzleri
infection were 30 days–90 years; there were slightly more
female than male patients. Fourteen patients were hospital-
ized for >48 h. Four patients had traveled abroad before
onset of symptoms. Ten patients had underlying disease: 4
were HIV seropositive, and 3 were immunocompromised
(postrenal graft, celiac disease, and chemotherapy for cere-
bellar astrocytoma). Other chronic illnesses included
dementia (n = 1), insulin-dependent diabetes mellitus
(n = 1), and hepatitis C (n = 1).
Thirty-one patients complained of acute diarrhea (>24
watery stools) lasting for 3 to 15 days, and 10 had persist-
ent or recurrent diarrhea lasting >2 weeks–2 months. Six
patients had abdominal pain without diarrhea. Twelve
patients were asymptomatic. Sixteen patients received
antimicrobial therapy, but only 7 were treated empirically
with an antimicrobial agent for which the strain was sus-
ceptible. The symptoms resolved in all patients except one,
regardless of the antimicrobial agent used. Among patients
treated symptomatically, three patients had persistent or
recurrent symptoms.
Sixty-seven patients with A. butzleri  infection were
matched against 201 patients with C. jejuni infection. The
age and sex distributions were similar for patients colo-
nized by each species. No significant differences in inter-
national travel were observed. However, proportionally
fewer patients with A. butzleri (79.1%) were treated as out-
patients than those with C. jejuni (90.5%) (OR 0.40, 95%
CI 0.17–0.90) (Table 2). 
Rectal bleeding, inflammatory exudates, or both were
significantly less common in A. butzleri than in C. jejuni
infection (OR 0.15, 95% CI 0.05–0.46). A concomitant
infection with another enteric pathogen occurred in a high-
er proportion of patients with A. butzleri infection than
patients with C. jejuni infection, but the difference was not
significant. Twelve patients with A. butzleri infection had
a coinfection with one of the following enteric pathogens:
Salmonella enterica (n = 4) (2 ser. Enteritidis, 1 ser.
Typhimurium and 1 ser. Virchow), Rotavirus (n = 3), C.
jejuni (n = 2), Giardia lamblia (n = 2), and Clostridium dif-
ficile toxin B positive (n = 1). 
In 24 patients with Campylobacter jejuni infection, we
found a coinfection with one another enteric pathogen: S.
enterica (7) (3 ser. Enteritidis, 3 ser. Typhimurium, and 1
ser.Virchow), Rotavirus (5), Adenovirus (4), Giardia lam-
blia (2), Shigella flexneri (2), Yersinia enterocolitica (1),
and Clostridium difficile toxin B positive (1). In two addi-
tional cases of campylobacteriosis, we found a coinfection
with two other enteric organisms: one patient was infected
with S. dysenteriae and Hymenolepis nana and the other
patient with Rotavirus and Salmonella enterica serotype
Typhimurium.
To assess the prevalence of A. butzleri and
Campylobacter jejuni in diarrheic stool specimens, we
considered only stools with loose or liquid macroscopic
aspect as diarrhea. Among the 67,599 stool specimens
received, 12,413 were solid stools, and 55,186 were diar-
rheic. Among the diarrheic stool specimens, we isolated A.
butzleri and C. jejuni in 77 (0.14%) and 3,209 (5.81%)
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 10, October 2004 1865
Arcobacter Species in Humansstools, respectively. Among the nondiarrheic stool speci-
mens, we isolated A. butzleri and C. jejuni in 7 (0.06%)
and 205 (1.65%) stools, respectively. A. butzleri was more
frequently isolated from diarrheic stool specimens than
from nondiarrheic stools specimens. This difference was
significant (OR 2.48, 95% CI 1.10–5.86) (p = 0.0175). We
observed a similar result for the recovery of C. jejuni from
diarrheic stool specimens compared with nondiarrheic
stools specimens. This difference was even more signifi-
cant (OR 3.68, 95% CI 3.18–4.25) (p < 0.0001).
Because medical records were unavailable for 6
patients with A. butzleri and 10 patients with C. jejuni, we
compared the clinical features of 61 patients with A. butz-
leri matched against those of 191 patients with C. jejuni.
Although diarrhea was a common clinical feature of both
groups, it was more frequent in the C. jejuni–infected
patients. The characteristics of the diarrhea differed signif-
icantly, however. Patients with A. butzleri were more like-
ly to have persistent diarrhea (OR 3.97, 95% CI 1.4–11.3),
or watery diarrhea (OR 2.20, 95% CI 1.18–4.13) than
those with C. jejuni infection, but they were less likely to
have acute diarrhea (OR 0.38 95%, CI 0.20–0.79). Other
clinical features did not differ significantly. Asymptomatic
carriage was more frequently encountered in patients with
A. butzleri infection than in those with C. jejuni infection,
but not significantly (OR 2.22, 95% CI 0.94–5.21).
Proportionally more patients with C. jejuni infections
were treated with antimicrobial agents (41.4%) than
patients with A. butzleri infections (26.2%) (OR 0.50, 95%
CI 0.25–1.0). Among them, only 43.8% of patients with A.
butzleri infections were treated empirically with an antimi-
crobial agent for which the strain was susceptible, where-
as 79.5% of patients with C. jejuni received an appropriate
antimicrobial drug.
Conclusions
In this study, Arcobacter was the fourth most common
Campylobacter or Campylobacter-like organism isolated
from stool specimens in our laboratories. Our observations
suggest that A. butzleri display similar microbiologic and
clinical features as C. jejuni. However, compared with C.
jejuni, A. butzleri are more frequently associated with a
persistent and watery diarrhea and less associated with
bloody diarrhea. This first study on Arcobacter in humans
could be the beginning of future research to better under-
stand the pathogenesis and epidemiology of these
non–jejuni/coli Campylobacter. 
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